Reprint

New Insights on Biofilm Antimicrobial Strategies

Edited by
July 2021
264 pages
  • ISBN978-3-0365-1221-1 (Hardback)
  • ISBN978-3-0365-1220-4 (PDF)

This book is a reprint of the Special Issue New Insights on Biofilm Antimicrobial Strategies that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary
Over the last few decades, the study of microbial biofilms has been gaining interest among the scientific community. These microbial communities comprise cells adhered to surfaces that are surrounded by a self-produced exopolymeric matrix that protects biofilm cells against different external stresses. Biofilms can have a negative impact on different sectors within society, namely in agriculture, food industries, and veterinary and human health. As a consequence of their metabolic state and matrix protection, biofilm cells are very difficult to tackle with antibiotics or chemical disinfectants. Due to this problem, recent advances in the development of antibiotic alternatives or complementary strategies to prevent or control biofilms have been reported. This book includes different strategies to prevent biofilm formation or to control biofilm development and includes full research articles, reviews, a communication, and a perspective.
Format
  • Hardback
License
© by the authors
Keywords
antibiofilm; antimicrobial agent; bacteria; fungi; polymicrobial biofilm; microalga; free fatty acids; encapsulation; biofilm; chronic wounds; host response; S100A8/A9; biofilm; dental plaque; quorum sensing; microbial resistance; bacterial adhesion; blocking effect; hydrodynamics; parallel plate flow cell; carbon nanotubes; poly(dimethylsiloxane); adhesion; Escherichia coli; Biofilm; Public Engagement; Outreach; Control Strategies; Oral Biofilm; TiO2 nanofibers; electrospinning; biofilm prevention and control; multidrug-resistant bacteria; biomedical application; biofilms; biofilm inhibition; dental implants; bacteria; peri-implantitis; polyether-ether-ketone; Pseudomonas aeruginosa; Candida albicans; mixed-species biofilm analysis; flow cytometry; biofilm; bacteriophage therapy; prosthesis related infections; hardware infections; left ventricular assist devices; Acinetobacter baumannii; biofilm; antibiotic resistance; antibiotic tolerance; persister; biofilms; Escherichia coli; intraspecies community; EPS matrix; peptide nucleic acid-fluorescence in situ hybridization; urinary tract infections; catheter-associated urinary tract infections; confocal laser scanning microscopy; biofilms; antibiotic resistance; antibiotic tolerance; multidrug-resistant bacteria; recalcitrance; biofilm control; Klebsiella pneumoniae; KPC and OXA-48-like carbapenemases; Galleria mellonella infection model; linear oligoethyleneimine hydrochloride; bacteriophage; biofilm; Pseudomonas aeruginosa; endotracheal tube; n/a